Denali Therapeutics Inc. Annual General and Administrative Expense in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Denali Therapeutics Inc. quarterly/annual General and Administrative Expense history and growth rate from 2016 to 2023.
  • Denali Therapeutics Inc. General and Administrative Expense for the quarter ending September 30, 2024 was $24.9M, a 1.49% decline year-over-year.
  • Denali Therapeutics Inc. General and Administrative Expense for the twelve months ending September 30, 2024 was $100M, a 1.91% decline year-over-year.
  • Denali Therapeutics Inc. annual General and Administrative Expense for 2023 was $103M, a 14.2% increase from 2022.
  • Denali Therapeutics Inc. annual General and Administrative Expense for 2022 was $90.5M, a 14.4% increase from 2021.
  • Denali Therapeutics Inc. annual General and Administrative Expense for 2021 was $79.1M, a 31.1% increase from 2020.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $103M +$12.9M +14.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $90.5M +$11.4M +14.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $79.1M +$18.7M +31.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $60.3M +$13.8M +29.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $46.5M +$14.1M +43.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $32.3M +$16.7M +106% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $15.7M +$3.95M +33.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $11.7M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.